Synmosa Biopharma Corporation (4114.TWO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Synmosa Biopharma Corporation, with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 19.52x |
| P/B Ratio | 1.38x |
| P/S Ratio | 1.95x |
| Profitability | |
| Gross Margin | 41.0% |
| Operating Margin | 12.6% |
| Net Margin | 13.3% |
| EBITDA Margin | 18.1% |
| Liquidity | |
| Current Ratio | 2.95x |
| Quick Ratio | 1.98x |
| Leverage | |
| Debt/Equity | 0.29x |
YoY = year-over-year change. Source: FMP..